Vincent Sutton, MD
Ophthalmology · Lincoln, NENPI 1134126030
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $677 of the $863 with a category attached, or 78.4%. 10 manufacturers reported payments, led by AbbVie at 26.4% of the total. Reporting peaked in 2022 at $328 and has fallen 67.6% since, to $106 in 2024. That places this record below the midpoint for ophthalmology clinicians in NE, where the typical reported total is $747.
Across 30 payments — averaging $28.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$227
- Tosoh Bioscience, Inc.$186
- Optos, Inc.$158
- Amgen$126
- Alcon$68
- Tarsus Pharmaceuticals, Inc.$26
- plus $72 from 4 others
What the payments were for
- Food & beverage$67778%
- Gifts$18622%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 15 | $227 |
| Tosoh Bioscience, Inc. | 1 | $186 |
| Optos, Inc. | 1 | $158 |
| Amgen(2 entities) | 7 | $126 |
| Alcon | 1 | $68 |
| Tarsus Pharmaceuticals, Inc. | 1 | $26 |
| Harrow Eye, LLC | 1 | $24 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $23 |
| Spark Therapeutics, Inc. | 1 | $13 |
| Apellis Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$863 in reported general payments places this provider in the 50th percentile of 105 ophthalmology providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 65 | $2,828 |
| Levobunolol Hcl | 71 | $1,945 |
| Brimonidine Tartrate | 209 | $1,918 |
| Latanoprost | 205 | $1,395 |
| Travoprost | 12 | $1,378 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 37 | $1,122 |
| Timolol Maleate | 103 | $996 |
| Ketorolac Tromethamine | 15 | $367 |
| Carteolol Hcl | 17 | $364 |
| Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim | 20 | $155 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Lincoln
- Samuel ThomsenLincoln$2K
- Lee ThurberLincoln$2K
- Gregory SuttonLincoln$1K
- John BaderLincoln$1K
- Thomas GraulLincoln$1K
- Mark YoungLincoln$949
- Randall DotsonLincoln$898
- Jordan RixenLincoln$747
- Mario MotaLincoln$609
- David BlodgettLincoln$603
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.